Market Overview

Valeant Fails To Reach $100 On Intra-Day Basis For The First Time Since September 2013

Related VRX
Benzinga's Option Alert Recap From October 18
Benzinga's Option Alert Recap From October 17
TB Alternative Assets Ltd. Buys Alibaba Group Holding, Baozun Inc, Amazon. ... (GuruFocus)

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares are trading lower by $4.23 at $93.63 in Wednesday's session.

Off the open, it failed to reach triple digits on an intra-day basis for the first time since September 13, 2013, when it peaked at $99.50. Since making the high, it has declined to $92.29 and has not been about to mount much of a rally.

There is one daily support level ahead of the low for the recent down move that stands at its October 30 low ($90.46).

Joel Elconin is the co-host of Benzinga's #PreMarket Prep, a daily trading idea radio show.

Do you like this article? Do you have suggestions for improvement? Please email

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (VRX)

View Comments and Join the Discussion!

Partner Center